PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma

Clinical trial NCT05380635 · COMPLETED

Trial details

NCT number: NCT05380635
Sponsor: Soligenix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Start date: 2022-05-09
Primary completion: 2022-08-16
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.